share_log

Maxim Group Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $45

Maxim Group Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $45

Maxim Group開始對Nutex Health進行買入評級,宣佈目標股價爲45美元。
Benzinga ·  09/18 08:33  · 評級/大行評級

Maxim Group analyst Anthony Vendetti initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $45.

Maxim Group分析師Anthony Vendetti發起對Nutex Health(納斯達克:NUTX)的覆蓋,並給予買入評級並公佈了45美元的目標價格。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論